Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HTX-011 vs Standard Practice in Total Knee Arthroplasty
NCT05188053Phase 4Completed
- Sponsor
- Mayo Clinic
- Start
- Mar 2022
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine + meloxicam in postoperative pain, sponsored by Mayo Clinic. Started Mar 2022; status: completed.
02
Drugs
bupivacaine + meloxicam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05188053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05188053.